How do I choose between different serialization and track-and-trace platforms for a generic pharma supply chain?

Choosing a serialization and track-and-trace platform for a generic pharma supply chain is mostly about matching the platform to your regulatory footprint, manufacturing model, packaging complexity, and partner network. “Best” is usually the one that minimizes compliance risk and integration pain while supporting your future expansion.

1) Start with the compliance requirements

Make a list of the markets you supply today and plan to supply next.

Key questions:

• Do you need support for DSCSA (US), EU FMD, Russia/other country-specific serialization, or multiple regimes?
• Does the platform handle:
  • Serialization
  • Aggregation
  • Commissioning/decommissioning
  • Case aggregation
  • Verification/returns
  • Recalls and traceability
• Can it generate and manage the required reports, audit trails, and event data?
• Does it support your required data standards such as GS1 EPCIS/CBV, and can it exchange data with external partners and regulators?

If you operate in multiple markets, prioritize platforms with strong multi-country rule engines and frequent regulatory updates.

2) Match the platform to your operational model

Generic pharma supply chains vary a lot. Your packaging and distribution setup matters as much as the software.

Consider:

• Multiple contract manufacturing organizations (CMOs) or packaging sites?
• Internal packaging lines vs outsourced serialization?
• High-volume, low-margin SKUs common in generics?
• Frequent artwork/pack changes?
• Complex aggregation to ship through wholesalers and 3PLs?
• Returns-heavy or sample-heavy operations?

For generics, I’d especially focus on:

• Line performance impact: serialization shouldn’t slow packaging materially.
• Exception handling: rework, rejected codes, and line stoppages.
• Master data governance: generics often have many SKUs, pack sizes, and markets.

3) Evaluate integration capabilities

The platform should fit into your existing IT stack, not force a replacement.

Check compatibility with:

• ERP: SAP, Oracle, Microsoft Dynamics, etc.
• MES / L4 line systems
• WMS / TMS
• Labeling systems
• Partner/3PL systems
• Cloud or on-prem infrastructure

Ask:

• Does it have prebuilt connectors or APIs?
• Can it integrate with your artwork and label management process?
• How does it handle master data synchronization?
• Does it support near real-time events and partner acknowledgments?

A platform can look strong in demos but fail in the “last mile” of integration.

4) Assess scalability and architecture

Pick a platform that can grow with your market expansion and SKU complexity.

Look for:

• Cloud-native vs on-prem deployment flexibility
• Ability to support multiple sites and CMOs
• Good performance for high transaction volumes
• High availability, disaster recovery, and data retention
• Support for global enterprise governance with local execution

If you have many packaging lines or external partners, make sure the architecture can handle:

• Centralized code management
• Distributed execution
• Serialization data reconciliation across sites

5) Focus on usability and exception management

In real operations, the best platform is the one operators can use under pressure.

Evaluate:

• Operator workflow design
• Ease of handling line exceptions
• Batch/lot reconciliation
• Role-based dashboards
• Quality and supply chain visibility
• Training burden for plant staff and partners

Ask for a live demo using your own use case, not a generic one. Simulate:

• code rejection
• carton rework
• partial aggregation
• order cancellation
• return verification
• recall scenario

6) Look at partner and network readiness

Serialization is collaborative. Your platform needs to work beyond your own four walls.

Check support for:

• CMOs and packers
• Wholesalers and 3PLs
• DSCSA trading partner workflows
• Data exchange formats and validation
• Onboarding tools for external partners

If you have many trading partners, network effects matter:

• How easy is it to onboard a new partner?
• Do they already support the platform?
• Is there a burden on your team to manage connections?

7) Compare vendor support and implementation quality

For pharma serialization, implementation quality often matters more than feature lists.

Assess:

• Vendor track record in generic pharma
• Number of successful go-lives
• Availability of local support
• Regulatory expertise
• Validation/documentation support
• Upgrade policy and release cadence

Ask for:

• Reference customers similar to your business
• Average implementation timeline
• Typical line downtime during deployment
• Support response SLAs
• Validation package and IQ/OQ/PQ assistance

8) Consider total cost of ownership, not just license fees

A low-cost platform can become expensive if integration and operations are painful.

Include:

• License/subscription fees
• Implementation and validation costs
• Integration development
• Hardware and scanners/vision systems
• Training
• Ongoing support
• Upgrades and revalidation
• Partner onboarding costs

For generics, ROI often depends on how much the solution reduces:

• manual exception handling
• line inefficiency
• recall costs
• compliance penalties
• duplicate serialization efforts across sites

9) Decide whether you need a point solution or a broader platform

There are generally two approaches:

Point solution

Good if:

• You have a narrow regulatory scope
• One or two packaging sites
• Simple integrations
• Limited partner complexity

Pros:

• Lower initial cost
• Faster deployment
• Easier to scope

Cons:

• May not scale well
• More likely to create data silos

Enterprise platform

Good if:

• Multiple sites/CMOs
• Multi-country compliance
• Complex supply chain visibility needs
• Long-term expansion plans

Pros:

• Better standardization
• Easier enterprise governance
• More robust traceability across the network

Cons:

• Higher upfront cost
• Longer implementation
• More change management

10) Use a weighted scorecard

A practical way to choose is to score each vendor against what matters most to you.

Example criteria:

• Regulatory coverage
• Integration capability
• Operator usability
• Aggregation and exception handling
• Scalability
• Partner connectivity
• Vendor support
• Validation effort
• Total cost of ownership
• Future roadmap

Weight the criteria based on your business model. For a generic pharma company, I’d usually give extra weight to:

• Compliance coverage
• Exception handling
• Low-cost scalability
• Integration with existing ERP/MES
• Partner interoperability

11) Pilot before committing

Before full rollout:

• Run a proof of concept
• Test with one SKU family and one site
• Include real packaging speeds and rejection scenarios
• Validate reporting and data exchange with at least one trading partner
• Measure line impact and operator workload

A pilot will tell you far more than a feature matrix.

---

A simple decision framework

Choose the platform that best answers these questions:

1. Can it keep us compliant in all required markets?
2. Will it work with our packaging lines and partners?
3. Can our operators use it reliably with minimal disruption?
4. Will it scale as our SKU and site count grow?
5. Is the vendor strong enough to support us long term?
6. Does the total cost make sense for a generic pharma margin structure?

If you want, I can also give you:

• a vendor evaluation scorecard template,
• a requirements checklist for RFPs, or
• a shortlist of key questions to ask platform vendors.